Publications, Reports and Books
A Survey of Education and Training in Life Sciences Commercialization
Education and training in the Life Sciences, and in Biotechnology has been indicated through a number of anecdotal assessments, and quantitative studies to be a major factor in the effective commercialization of products. Whether in production, R&D or on the business side, workforce issues continue to present challenges and competitive opportunities for life sciences companies. This study focuses on the impact that education and training is having on the commercialization of life sciences products and services.
We conducted a benchmarking study to evaluate the impact of levels of education and training in biotechnology. We surveyed 100 senior managers involved in the commercialization of technology, products and services at biotechnology companies in the United States and Canada. Respondents included senior managers, VP’s of marketing, sales, product managers, and others. The ability to meet the demand for a skilled workforce, whether through in-house training or out-sourced education, carries long-term strategic implications for companies and requires accurate needs assessment, and lead-time. This White Paper provides a quantitative assessment of the industry’s current situation, and offers a view into potential industry bottlenecks that may develop based on potential shortfalls in education and training
- Companies involved, and relationships
- Composition, biological and chemical aspects
- Manufacturing methods
- Patents and technology transfer
- Regulatory history and status
- Approved indications
- Market size and share
- Nomenclature
- Controversial aspects, and more!
- Recombinant & other proteins
- Monoclonal antibodies
- Vaccines, adjuvants
- Enzymes & toxins
- Blood products, human & animal-derived
- Radioimmune conjugates
- Cultured cells
- Tissue products
- Antisense drugs…And more!
- Bigger! 1,234 pages and 482 monographs and product entries
- Better! Now includes European/EU products;
- Indexes — 24,000+ index entries
- Includes all US, and European products, and many biodefense and biogeneric products
- Includes upcoming products in 2006
- Fresh! Up-to-date into May 2005